Page 33 - Read Online
P. 33

lesions detected by ultrasonography showing vascular   maintenance of blood glucose group and the non-diabetes
          enhancement with washout on triphasic CT or dynamic   group (P = 1.0000).
          MRI. If the tumor was not hypervascular, a tumor biopsy was
          performed to confirm the diagnosis.                 With regard to the number of HCC nodules, namely, solitary
                                                              or multiple, the recurrence rate was significantly higher in
          Statistical analysis                                patients with multiple HCC nodules in all groups. Within each
          All patients’ data were tabulated and processed using SPSS   subgroup of patients with single and multiple HCC nodules,
          10.0 (SPSS Inc., Chicago, USA). The data were presented by   diabetes with inadequate maintenance of blood glucose was
          mean and standard deviation and compared using one way   significantly associated with recurrence of HCC in comparison
          analysis of variance test. In addition, the data were presented   to other groups as shown in Figure 1 and Table 2. In terms
          by frequency and percent and compared using Chi-square   of the initial level of serum AFP ≥ 200 ng/mL, the recurrence
          test or Fischer’s exact test when appropriate. For analysis of   rate was significantly higher in patients with AFP ≥ 200 ng/mL
          survival and recurrence, the time of initial RFA treatment was   in all groups. Within each subgroup of patients with AFP
          defined as day 0. Survival rate was analyzed by the Kaplan-  ≥ 200 ng/mL and < 200 ng/mL, diabetes with inadequate
          Meier method and log rank test. Multivariate analysis was   maintenance of blood glucose was associated with a higher
          performed using a Cox proportional hazard model. In all tests   rate of recurrence in comparison to other groups as shown
          P value was considered significant if < 0.05.       in Figure 1 and Table 2. On the other hand, obesity was not

                                                              significantly associated with HCC recurrence in all groups.
          RESULTS
                                                              As shown in Figure 2, the survival rate was significantly
          The clinical and laboratory characteristics of patients   lower in diabetic patients with inadequate maintenance
          undergoing curative RFA for HCC are summarized in Table 1.  of blood glucose (solid line) than in diabetic patients with
                                                              adequate maintenance of blood glucose (blood glucose
          Our results showed that, upon comparison of the three groups,   < 200 mg/dL, broken line) or non-diabetic patients (dotted
          that is, the diabetes with inadequate maintenance   line) (P = 0.0060). There was no significant difference
          of blood glucose group (Group I), the diabetes with   in survival rate between diabetic patients with adequate
          adequate maintenance of blood glucose group (Group II),   maintenance of blood glucose and non-diabetic patients.
          and the euglycemic non-diabetes group (Group III), the
          recurrence rate was significantly higher in the diabetes with   DISCUSSION
          inadequate maintenance of blood glucose group than in the
          other two groups (P < 0.0001) [Figure 1 and Table 2]. On the   The effect of metabolic factors, such as hyperglycemia,
          other hand, there was no significant difference in the HCC
          recurrence rate between the diabetes patients with adequate   diabetes, and obesity, on the recurrence of HCC after curative
                                                              RFA therapy was analyzed retrospectively. Our results
                                                              identified that inadequate maintenance of blood glucose
          Table 1: The clinical and laboratory criteria for all patients
          undergoing RFA                                      in diabetic patients was a significant and independent risk
                                                              factor for early recurrence of HCC, whereas obesity and
          Variable             Group I   Group II   Group III
                               (n = 37)   (n = 25)  (n = 45)
                               (52 HFL)  (43 HFL)  (64 HFL)
                                                                100.00
          Age (years)         50.8 ± 8.6  53.4 ± 9.4  50.9 ± 8.6
                                                                90.00
          Sex (male/female)     27/10    15/10      28/17       80.00
                                                                70.00
          ALT (IU/L)           57.7 ± 15  59.7 ± 17.9  61 ± 18.2  60.00                                  Group I
          AST (IU/L)            50 ± 7  54.4 ± 11.4  50.3 ± 13.4  50.00                                  Group II
                                                                40.00                                    Group III
          Child-Pugh grade (A/B)  17/20  13/12      20/25       30.00
          Casual blood sugar (mg/dL) 159.9 ± 7.47 262.0 ± 44.35 121.3 ± 25.7  20.00
                                                                10.00
          Maximum diameter of   3.17 ± 0.51  3.11 ± 0.53  3.16 ± 0.46  0.00
          HCC (cm)
          Number of patient with   24/11/2  9/14/2  28/15/2
          1/2/3 HCC
          AFP (ng/mL)         170.3 ± 160 169.5 ± 139.9 182.6 ± 153.3
          AFP  200 (ng/mL)     21/37    15/25      28/45
          BMI (kg/m )         27.9 ± 0.5  27.2 ± 2.9  26.5 ± 3.1
                  2
          RFA: radiofrequency ablation; ALT: alanine aminotransferase; AST: aspartate
          aminotransferase; HCC: hepatocellular carcinoma; AFP: alpha-fetoprotein;   Figure 1: The recurrence of all studied patients as regard all risk factors after
          BMI: body mass index; HFL: hepatic focal lesion     radiofrequency ablation (AFP: alpha-fetoprotein; BMI: body mass index)

          26                                                          Hepatoma Research | Volume 1 | Issue 1 | April 15, 2015
   28   29   30   31   32   33   34   35   36   37   38